BioCentury
ARTICLE | Distillery Therapeutics

Blocking platelet serotonin signaling to reduce age-related COVID-19 lung injury

September 9, 2026 1:05 AM UTC

Blocking platelet serotonin signaling could reduce severe age-related lung dysfunction in SARS-CoV-2 infection by suppressing platelet procoagulant activity. Middle-aged mice and aged human donors sho...